We have previously demonstrated cytokine-mediated, signal transducer and activator of transcription 3 (STAT3)-coordinated amoeboid migration as the culprit of lymphoma dissemination, and combining a JAK inhibitor with a microtubule stabilizer could serve as a mechanism-derived therapeutic approach in DLBCL [16]. This evidence concerns the gene STAT3 and lymphoma.